Suppressed Alzheimer’s Therapies and Cures

I have a passionate connection to Alzheimer’s research and an equally passionate hate against greed, fraud, and corruption, especially when it comes to Alzheimer’s research, because of my own extensive research on the subject beginning in the year 2000, when my mom was diagnosed with early-onset Alzheimer’s. She passed away in 2005, but I never stopped studying it because science was changing so fast, and I knew there would be better, more effective ways to help other people.

Most of the truly effective therapies and cures are being suppressed (especially the natural ones) because big Pharma and big money attract greedy scientists and corporations that would rather make a profit than see people healed. This is why I write so many posts on this subject, including this one. To find the others, scroll down to the bottom of the X Gym.com home page and type in the word dementia in the search box to see them all.

I am not a doctor, so I’m never giving medical advice. I am a voracious researcher of truth and science. Most doctors don’t do that. They stop most of their learning when they graduate from the Rockefeller medical school system, and keep coasting on that. I choose to look for truth, especially the truth that has been systematically censored and suppressed by the “establishment.” That’s usually where the absolute truth lives.

Real science and real truth don’t mind being challenged (in fact, that is the basis of real science), but fraud, greed, and lies surely hate challenge, and they attack the truth relentlessly when they see it come out. If you see them ignoring something, that’s because it doesn’t work. If you see a coordinated attack against something else, that’s a good indication it’s effective, and that they couldn’t make any money from it.

If this opinion offends you or elicits strong negative emotions, stick with what you trust; there’s no point reading further in this post or any of my other posts. I sincerely wish you good luck in your journey because you will certainly need it. The allopathic success rate with all forms of dementia is atrocious, but I certainly want you to have better results than the norm. Hopefully, you will be an outlier. My mom wasn’t. She went with allopathic because back then, that’s all we knew. Now we know so much more, and it’s very, very exciting.

The Amyloid Research Paradigm and Fraud

  • The Amyloid Hypothesis: For decades, Alzheimer’s research has focused on the elimination of amyloid plaques. This model posits that these protein deposits are the primary drivers of neurodegeneration.

  • Scientific Misconduct: A seminal 2006 paper in Nature regarding the toxic oligomer was found to contain doctored Western blots. This fraudulent data steered billions in NIH and private funding toward a flawed premise.

  • Institutional Inertia: Despite notification of fraud in 2022, the NIH continued to fund the suspect researchers. The 2006 paper was not retracted until June 2024.

Failure of Conventional Therapeutics

  • Minimal Efficacy: FDA-approved monoclonal antibodies (such as Aduhelm and others) targeting amyloid have shown negligible clinical benefits, often failing to reach the 1 to 2-point improvement threshold required for patient significance.

  • Severe Side Effects: These drugs are associated with Amyloid-Related Imaging Abnormalities (ARIA), specifically brain swelling and hemorrhaging, occurring in 21% to 41% of trial participants.

  • Conflicts of Interest: Reports indicate that many members of the FDA advisory panels approving these drugs held significant financial ties to the pharmaceutical industry.

DMSO as a Neuroprotective Alternative

  • Mechanisms of Action: Dimethyl Sulfoxide (DMSO) exhibits properties that rescue dying tissue and counteract the inflammatory processes associated with dementia.

  • Clinical and Preclinical Evidence: * Animal Studies: DMSO has been shown to improve memory and spatial learning in rats by 54% following reduced cerebral blood flow. It also protects against neuronal loss in models of early-onset Alzheimer’s.

    • Human Trials: Research involving patients with probable Alzheimer’s showed significant improvements in memory, concentration, and orientation after three months of DMSO treatment.

    • Cerebrovascular Recovery: In studies of 100+ elderly patients, DMSO combined with amino acids improved motor function and cognitive clarity in cases of Parkinson’s and vascular dementia.

Alternative Protocols and Root Causes

  • The RECODE Protocol: This approach focuses on identifying the specific underlying cause of cognitive impairment (e.g., inflammation, toxins, or trophic loss) rather than a one-size-fits-all biochemical fix.

  • Metabolic Support: Randomized controlled trials utilizing Medium Chain Triglycerides (MCTs) from coconut oil demonstrated that 80% of patients remained stable or improved over six months, outperforming the results of high-cost amyloid drugs.


References